SEARCH RESULTS FOR: (*cloud mining with parvez馃挷itenthusiasts.com馃挷Crypto*)(10185 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

SonicOne O.R. Curette Style Titanium Probe Kit
MISONIX, INC.
MXC-C1
In Commercial Distribution

  • 00841626101371 ()
  • 10841626101378 ()


  • Soft-tissue ultrasonic surgical system handpiece tip, single-use
SonicOne O.R. Extra Large Blade
MISONIX, INC.
MXC-BLADE-XL
In Commercial Distribution

  • 00841626101357 ()
  • 10841626101354 ()


  • Soft-tissue ultrasonic surgical system handpiece tip, single-use
SonicOne O.R. Small Blade
MISONIX, INC.
MXC-BLADE-S
In Commercial Distribution

  • 00841626101333 ()
  • 10841626101330 ()


  • Soft-tissue ultrasonic surgical system handpiece tip, single-use
SonicOne O.R. Large Blade, Serrated
MISONIX, INC.
MXC-BLADE-LS
In Commercial Distribution

  • 00841626101319 ()
  • 10841626101316 ()


  • Soft-tissue ultrasonic surgical system handpiece tip, single-use
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL090A
In Commercial Distribution

  • 14540778171395 ()
  • 04540778171398 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL105A
In Commercial Distribution

  • 04540778171381 ()
  • 14540778171388 ()

  • Length: 105 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube
37cm iQ Large
STRYKER CORPORATION
550025S601
In Commercial Distribution

  • 37613327576628 ()
  • 07613327576627 ()
5500-25S-601

  • Soft-tissue ultrasonic surgical system handpiece tip, single-use
SIlver Alginate Dressing (Rope)
VIVE HEALTH LLC
RHB2076R
In Commercial Distribution

  • 10810178880642 ()
  • 00810178880645 ()


  • Exudate-absorbent dressing, hydrophilic-gel, antimicrobial
< 1 ... 887 888 889 890 891 ... 1000 >